Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

The challenges of modeling hormone receptor-positive breast cancer in mice in: Endocrine-Related Cancer Volume 25 Issue 5 (2018)

Cancers, Free Full-Text

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands

Frontiers Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study

The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB)

Current Oncology, Free Full-Text

Association between low estrogen receptor positive breast cancer and staining performance

Estrogen/Progesterone Receptors (ER/PR Receptors)

Simplified ER and HER2 signalings' cross-talk. Estrogens (E) act via a

Loss of PR reduces the ESR1 expression in hormone-deprived T47D breast

Estrogen/Progesterone Receptors (ER/PR Receptors)

Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation